| In ZINC since | Heavy atoms | Benign functionality |
|---|---|---|
| October 6th, 2004 | 19 | No |
Popular Name: Thalidomide Thalidomide
Find On: PubMed — Wikipedia — Google
CAS Numbers: 2614-06-4 , 50-35-1 , 50-35-1; 731-40-8 , 731-40-8 , 841-67-8 , [50-35-1]
( inverted question mark)-Thalidomide
(+-)-Thalidomide; LS-109463; Phthalimide, N-(2,6-dioxo-3-piperidyl)-, (+-)-; Thalidomide (+ and -)
(-)-thalidomide; (S)-(-)-thalidomide; L-thalidomide; S-(-)-thalidomide; l-thalidomide
(±)-N-(2,6-dioxo-3-piperidyl)phthalimide
.alpha.-(N-Phthalimido)glutarimide
.alpha.-Phthalimidoglutarimide
1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)isoindoline
1H-isoindole-1,3(2H)-dione, 2-(2,6-dioxo-3-piperidinyl)-
2,6-dioxo-3-phthalimidopiperidine
2-(2,6-Dioxo-3-piperidinyl)-1H-isoindole-1,3(2H)-dione
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione
2-(2,6-dioxopiperidin-3-yl)-2,3-dihydro-1H-isoindole-1,3-dione
2-(2,6-Dioxopiperidin-3-yl)isoindoline-1,3-dione
2-[(3S)-2,6-Dioxo-3-piperidinyl]-1H-isoindole-1,3(2H)-dione
50-35-1; CPD000058524; SAM002564245; Thalidomide
50-35-1; D00754; Thaled (TN); Thalidomide (JAN/USP/INN); Thalomid (TN)
50-35-1; Prestwick_463; Thalidomide
alpha-(N-Phthalimido)glutarimide
CPD000058524; SAM002564245; Thalidomide
Distaval; K-17; Sedalis; Softenon; Talimol
N-(2,6-dioxo-3-piperidyl)phthalimide
N-Phthalimidoglutamic acid imide
N-Phthalyl-glutaminsaeure-imid
N-Phthalyl-glutaminsaeure-imid [German]
Phthalimide, N-(2,6-dioxo-3-piperidyl)-
talidomida; thalidomide; thalidomidum
| Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
|---|---|---|---|---|---|---|---|---|---|---|
| Ref Reference (pH 7) | 0.34 | 2.64 | -15.5 | 1 | 6 | 0 | 85 | 258.233 | 1 | ↓ |
| Note Type | Comments | Provided By |
|---|---|---|
| ALOGPS_SOLUBILITY | 2.55e+00 g/l | DrugBank-withdrawn |
| MP | 269 - 271 °C | Fluorochem |
| purity | 9.500000000000000e+001 | Enamine Building Blocks Enamine Building Blocks |
| Purity | 99% | APIChem |
| Purity | >99% | Fluorochem |
| UniProt Database Links | CRBN_DANRE; CRBN_HUMAN | ChEBI |
| Target | E3 Ligase ,TNF-alpha | Selleck Chemicals |
| Therapy | hypnotic | SMDC Iconix |
| PUBCHEM_SUBSTANCE_COMMENT | NCC_SAMPLE_SUPPLIER : LightBiologicals; NCC_SUPPLIER_STRUCTURE_ID : T-7743; NCC_SUPPLIER_SAMPLE_COMMENTS : WHITE POWDER | NIH Clinical Collection via PubChem |
| Target | Others | Selleck Chemicals |
| PUBCHEM_SUBSTANCE_COMMENT | SAMPLE_SUPPLIER: LightBiologicals; SUPPLIER_STRUCTURE_ID: T-7743; SUPPLIER_COMMENTS: WHITE POWDER | NIH Clinical Collection via PubChem |
| Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
|---|---|---|---|---|---|
| PGH1-3-E | Cyclooxygenase-1 (cluster #3 Of 6), Eukaryotic | Eukaryotes | 370 | 0.47 | Binding ≤ 10μM |
| PGH2-3-E | Cyclooxygenase-2 (cluster #3 Of 8), Eukaryotic | Eukaryotes | 500 | 0.46 | Binding ≤ 10μM |
| Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
|---|---|---|---|---|---|
| PGH1_HUMAN | P23219 | Cyclooxygenase-1, Human | 370 | 0.47 | Binding ≤ 1μM |
| PGH2_HUMAN | P35354 | Cyclooxygenase-2, Human | 500 | 0.46 | Binding ≤ 1μM |
| PGH1_HUMAN | P23219 | Cyclooxygenase-1, Human | 370 | 0.47 | Binding ≤ 10μM |
| PGH2_HUMAN | P35354 | Cyclooxygenase-2, Human | 500 | 0.46 | Binding ≤ 10μM |
| Description | Species |
|---|---|
| COX reactions | |
| Nicotinamide salvaging | |
| Synthesis of 15-eicosatetraenoic acid derivatives | |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) |